Michal Andrä

Michal Andrä is a scientist specializing in medicinal chemistry at Redx Pharma since September 2020. Previously, Michal Andrä held postdoctoral researcher positions at Ruhr University Bochum, focusing on project finalization, and at The Scripps Research Institute, where the emphasis was on stereoselective CH-activation. Additionally, Michal Andrä completed postdoctoral work at Freie Universität Berlin to finalize a PhD project in retinal chemistry and served as a chemistry teacher at Humboldt-Gymnasium. Early career experiences included internships at BASF, Bayer, and tesa SE, covering various aspects of chemical research and development. Michal Andrä holds a PhD in organic chemistry and a master's degree in chemistry from Freie Universität Berlin.